ZR2 Bioenergy Limited (BOM:506640)
India · Delayed Price · Currency is INR 125.85
+3.50 (2.86%)
At close: Sep 11, 2026
ZR2 Bioenergy Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 188.44 | 190.94 | 43.11 | 3.29 | 13.34 |
Cash & Short-Term Investments | 188.44 | 188.44 | 190.94 | 43.11 | 3.29 | 13.34 |
Cash Growth | -1.31% | -1.31% | 342.88% | 1212.13% | -75.38% | 459.03% |
Accounts Receivable | - | - | 0.24 | 18.57 | 1.02 | 11.79 |
Other Receivables | - | 12.46 | 4.53 | 1.22 | 0.85 | 0.91 |
Receivables | - | 12.46 | 4.76 | 19.78 | 1.87 | 12.7 |
Prepaid Expenses | - | - | - | 0.01 | 0 | - |
Other Current Assets | - | 5.75 | 3.39 | 310.47 | 122.34 | 0.91 |
Total Current Assets | - | 206.65 | 199.09 | 373.37 | 127.5 | 26.95 |
Property, Plant & Equipment | - | 1,205 | 1,195 | 0.11 | 0.27 | 0.29 |
Long-Term Investments | - | - | - | 17.62 | 35.67 | 17.65 |
Long-Term Deferred Tax Assets | - | 0.3 | - | 1.11 | 0.76 | 0.73 |
Other Long-Term Assets | - | 1.35 | 1.35 | 0 | 0 | 0 |
Total Assets | - | 1,413 | 1,395 | 392.21 | 164.21 | 45.63 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 2.33 | 0.86 | - | - | 0.62 |
Accrued Expenses | - | - | - | 2.91 | 0.3 | 1.12 |
Current Income Taxes Payable | - | 3.08 | - | 0.59 | 0.05 | 0.5 |
Other Current Liabilities | - | 7.97 | 0.71 | 0.07 | 0 | 0 |
Total Current Liabilities | - | 13.38 | 1.57 | 3.58 | 0.36 | 2.24 |
Long-Term Debt | - | - | - | 220.09 | 120.1 | - |
Long-Term Deferred Tax Liabilities | - | - | 0.01 | - | - | - |
Total Liabilities | - | 13.38 | 1.58 | 223.67 | 120.46 | 2.24 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 3.57 | 3.57 | 3.57 | 1.62 | 1.62 |
Additional Paid-In Capital | - | - | 118.95 | 118.95 | - | - |
Retained Earnings | - | - | 29.78 | 28.88 | 24.98 | 24.63 |
Comprehensive Income & Other | - | 1,396 | 1,241 | 17.15 | 17.15 | 17.15 |
Shareholders' Equity | 1,400 | 1,400 | 1,393 | 168.54 | 43.75 | 43.39 |
Total Liabilities & Equity | - | 1,413 | 1,395 | 392.21 | 164.21 | 45.63 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | - | 220.09 | 120.1 | - |
Net Cash (Debt) | 188.44 | 188.44 | 190.94 | -176.98 | -116.82 | 13.34 |
Net Cash Growth | -1.31% | -1.31% | - | - | - | 459.03% |
Net Cash Per Share | 21.02 | 11.82 | 4.56 | -56.32 | -72.16 | 8.24 |
Filing Date Shares Outstanding | 3.55 | 3.55 | 3.57 | 3.57 | 1.62 | 1.62 |
Total Common Shares Outstanding | 3.55 | 3.55 | 3.57 | 3.57 | 1.62 | 1.62 |
Working Capital | - | 193.27 | 197.52 | 369.79 | 127.14 | 24.72 |
Book Value Per Share | 394.08 | 394.08 | 390.44 | 47.23 | 27.02 | 26.80 |
Tangible Book Value | 1,400 | 1,400 | 1,393 | 168.54 | 43.75 | 43.39 |
Tangible Book Value Per Share | 394.08 | 394.08 | 390.44 | 47.23 | 27.02 | 26.80 |
Buildings | - | - | 0.22 | 0.22 | 0.76 | 0.76 |
Machinery | - | - | 6.81 | 1.5 | 1.5 | 1.5 |
Construction In Progress | - | - | 1,190 | - | - | - |